Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-062400

SVP, Chief Accounting Officer sold 2,031 shares at $43.96 ($89,283)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Huizenga Theodore Alan SVP, Chief Accounting Officer 2022-12-21 Sale −2,031 $43.96 $89,283 16,197 D: show line 1 in the form
Open-market sales · 2,031 sh · avg $43.96 · $89,283
Loading xslF345X03/doc4.xml…